Axsome Therapeutics, a biopharmaceutical company focused on central nervous system disorders, announced its participation in two upcoming investor conferences in May 2026: the BofA Securities Health Care Conference on May 12 in Las Vegas and the RBC Capital Markets Global Healthcare Conference on May 19 in New York. The company will host fireside chats at both events and provide live webcasts accessible through its website, with replays available for 30 days. These presentations offer investors insights into Axsome's progress and future plans in developing treatments for neurological and psychiatric conditions affecting millions in the U.S.
Candel Therapeutics is shifting from a risky clinical-stage biotech to a late-stage oncology company, driven by its lead asset CAN-2409 which showed positive Phase III results in localized prostate cancer. Additional promising data in non-small cell ...
The paper company reported Q1 EBITDA slightly above expectations despite weather disruptions, supported by lower industry supply, declining imports, price increases, and better utilization rates. Conservative recovery assumptions estimate an adjusted...
MediaAlpha reported Q1 revenue of $310 million and adjusted EBITDA of $31.4 million, surpassing guidance due to increased participation from insurance carriers and strong growth in property and casualty (P&C) insurance. The company now generates 93% ...
French President Emmanuel Macron and Indian Prime Minister Narendra Modi are actively courting major tech CEOs to secure investments in AI data centers, cloud infrastructure, and semiconductor development. Macron successfully persuaded SoftBank to in...
XRP rose over 5% as traders focused on Ripple's expanding cross-border payments network and improving regulatory outlook in the U.S. Despite some resistance near $1.20, XRP's short-term momentum is positive with growing adoption expectations for the ...
